SEC Form 4 · accession 0001562180-19-001843
vTv Therapeutics Inc. · VTVT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rudy Howard
Officer — CFO & Secretary
Period of report
Mar 7, 2019
Accepted (ET)
Mar 11, 2019 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641489
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $2.18 | Mar 7, 2019 | A | 125,000 | A | — | Mar 7, 2029 | Class A Common Stock | 125,000 | 344,914 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning on March 7, 2020.